Ellen M. Christensen, MD | Psychiatrist.com

Original Research

Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

July 8, 2014

Kamilla W. Miskowiak, Hannelore Ehrenreich, Ellen M. Christensen, et al